Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Galderma launches phase 3 atopic dermatitis trial for nemolizumab Galderma, a Nestle-owned Swiss pharma company, said that it has enrolled the first patients in a phase 3… bypharmanewsdailyOctober 11, 2019